Lauren Rusckowski Duprey sold $640K of Takeda Pharmaceutical Company Limited (TAK)

Executed Sep 14, disclosed Sep 16, 1 day later.

Value, as filed

$640K

34,535 sh × $18.54

Executed

Sep 14

the trade date, as filed

Disclosed

Sep 16

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Lauren Rusckowski Duprey Chief Transformation Officer profile →

Lauren Rusckowski Duprey (Chief Transformation Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Takeda Pharmaceutical Company Limited (TAK). The largest single filing was $814K of TAK (47,586 sh × $17.10, as filed), executed Aug 10.

The name

TAK

Takeda Pharmaceutical Company Limited TAK · Healthcare · 19 filings in 24 months ticker →

Healthcare · Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical pro…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Lauren Rusckowski Duprey in TAK

TAKSALE Takeda Pharmaceutical Company Limited $814K
47,586 sh × $17.10
Exec Aug 10
Filed Aug 12 · 9:51 PM ET